Le Lézard
Classified in: Health, Science and technology

Global Laboratory Automation Market (2019 to 2026) - Featuring Agilent Technologies, BioMerieux & Danaher Corporation Among Others - ResearchAndMarkets.com


The "Laboratory Automation Market by Product Type Application and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026" report has been added to ResearchAndMarkets.com's offering.

The global laboratory automation market was valued at $4,884 million in 2018, and is projected to reach $8,424 million by 2026, registering a CAGR of 6.9%.

Laboratory is a setting that is equipped to perform scientific experiments, carry out research, and execute analyses of different scientific materials. Laboratory automation is a multi-disciplinary innovative approach used in the laboratory to increase productivity, streamline workflows, improve quality, reduce times, and increase efficiency of the laboratory process. Automated laboratory systems are widely use in biotechnology & pharmaceutical industries, research institutes, hospitals and academic institutes to enhance workflow.

The laboratory automation market is expected to experience significant growth during the forecast period owing to growth in adoption of automated laboratory equipment in pharmaceutical & R&D institutes, technological advancement in lab automation systems, and rising demand for miniaturize process equipment. In addition, increase in productivity, improve efficiency, lower cost of operation, reduce fluctuation in the production and enhance safety significantly driving the market growth.

Key Players

Key Finding of The Laboratory Automation Market:

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Market Overview

3.1. Market Definition And Scope

3.2. Key Forces Shaping Laboratory Automation Market

3.2.1. Moderate Power Of Suppliers

3.2.2. High Threat Of New Entrants

3.2.3. High Threat Of Substitution

3.2.4. Moderate Competitive Rivalry

3.2.5. Moderate Bargaining Power Of Buyers

3.3. Market Dynamics

3.3.1. Drivers

3.3.1.1. Advantages Offered By Automated Laboratories

3.3.1.2. Surge In Adoption Of Laboratory Automation Systems

3.3.1.3. Increase In Number Of R&D Activities

3.3.2. Restraint

3.3.2.1. High Initial Capital Investments Required For Laboratory Automation

3.3.3. Opportunities

3.3.3.1. Growth Opportunities In Emerging Markets

3.3.4. Impact Analysis

4. Laboratory Automation Market, By Product

4.1. Overview

4.1.1. Market Size And Forecast

4.2. Equipment

4.2.1. Key Market Trends And Opportunities

4.2.2. Market Size And Forecast, By Type

4.2.3. Automated Workstations

4.2.3.1. Market Size And Forecast, By Type

4.2.3.2. Automated Liquid Handling

4.2.3.2.1. Market Size And Forecast, By Type

4.2.3.2.2. Standalone

4.2.3.2.3. Individual Benchtop Workstations

4.2.3.2.4. Multi-Purpose Instruments

4.2.3.2.5. Others

4.2.3.3. Microplate Readers

4.2.3.4. Automated Elisa Systems

4.2.3.5. Automated Nucleic Acid Purification Systems

4.2.4. Robotic Systems

4.2.5. Other Equipment

4.2.6. Market Size And Forecast, By Region

4.2.7. Market Analysis, By Country

4.3. Software & Informatics

4.3.1. Key Market Trends And Opportunities

4.3.1.1. Market Size And Forecast, By Type

4.3.2. Workstation/ Unit Automation Software

4.3.3. Laboratory Information Management System (Lims)

4.3.4. Electronic Laboratory Notebook

4.3.5. Scientific Data Management System

4.3.6. Market Size And Forecast, By Region

4.3.7. Market Analysis, By Country

5. Laboratory Automation Market, By Application

5.1. Overview

5.1.1. Market Size And Forecast

5.2. Drug Discovery

5.2.1. Market Size And Forecast, By Region

5.2.2. Market Analysis, By Country

5.3. Clinical Diagnostics

5.4. Genomics Solutions

5.5. Proteomics Solutions

6. Laboratory Automation Market, By End-User

6.1. Overview

6.1.1. Market Size And Forecast

6.2. Biotechnology & Pharmaceutical Industries

6.2.1. Market Size And Forecast, By Region

6.2.2. Market Analysis, By Country

6.3. Research Institutes

6.4. Others

7. Laboratory Automation Market, By Region

7.1. Overview

7.1.1. Market Size And Forecast

7.2. North America

7.2.1. Key Market Trends, Growth Factors, And Opportunities

7.2.2. Market Size And Forecast, By Country

7.2.2.1. U.S.

7.2.2.1.1. U.S. Laboratory Automation Market, By Product

7.2.2.1.2. U.S. Laboratory Automation Market, By Application

7.2.2.1.3. U.S. Laboratory Automation Market, By End User

7.2.2.2. Canada

7.2.2.3. Mexico

7.2.3. North America Laboratory Automation Market, By Product

7.2.4. North America Laboratory Automation Market, By Application

7.2.5. North America Laboratory Automation Market, By End User

7.3. Europe

7.4. Asia-Pacific

7.5. LAMEA

8. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/kl7giu


These press releases may also interest you

at 18:30
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the promotion of Dr. Bob Dagher to Executive Vice President and Chief Medical Officer. In addition, after four...

at 18:16
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 17:56
The Canadian Cancer Society commends the increases in taxes on tobacco and e-cigarettes in today's federal budget.  The budget increases tobacco taxes by $4.00 per carton of 200 cigarettes effective at midnight, and increases e-cigarette taxes by 12%...

at 17:45
Alvotech and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , today announced that the U.S. Food and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to...

at 17:31
The rise in demand for dental lasers is mainly driven by the growing occurrence of dental issues like bleeding or inflamed gums, tooth decay, and root infections. Furthermore, advancements in dental technology play a significant role in fostering...

at 17:26
Amgen today provided an update regarding the results of the Phase 2a COURSE trial for TEZSPIREŽ (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD), which were accepted for presentation in the Clinical Trials Symposium at The American...



News published on and distributed by: